My best ASX 200 shares to buy in January

There is a lot to like about these ASX 200 shares. Here's why they could be best buys.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL remains a dominant force in the global blood plasma market despite disappointing in 2025, with short-term headwinds like margin pressures and weak flu vaccine sales creating a potential buying opportunity for patient investors willing to look past temporary setbacks.
  • Macquarie's diversified earnings across asset management, infrastructure, and capital markets help smooth returns through economic cycles, with its global expertise positioning it well for long-term investment trends despite some recent underperformance.
  • Woolworths' shares have fallen meaningfully from their highs, but the supermarket giant's ongoing investments in automation and digital capability could pay off as margin pressures ease and the competitive environment stabilises.

A new year often brings fresh optimism for investors, and January can be a great time to revisit an investment portfolio.

But which ASX 200 shares could be great picks for investors right now?

Let's take a look at three that I think are among the best to buy this month and for 2026:

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.

Image source: Getty Images

CSL Ltd (ASX: CSL)

It may have disappointed in 2025, but CSL remains one of the highest-quality companies on the Australian share market. The global biotech leader dominates the blood plasma market and has a deep pipeline of therapies that should be supportive of long-term earnings growth.

Short-term issues, including margin pressures, albumin demand, and weak influenza vaccine sales, have weighed on sentiment. But these factors don't change the core investment case. Demand for plasma therapies continues to grow globally, barriers to entry are extremely high, and CSL's scale gives it a significant competitive advantage.

For patient investors, January could be an attractive time to accumulate shares while the market remains cautious, rather than chasing the stock once momentum returns.

Macquarie Group Ltd (ASX: MQG)

Macquarie is Australia's leading global investment bank. Its earnings are diversified across asset management, infrastructure, commodities, and capital markets. This helps smooth returns across economic cycles.

While there has been underperformance in parts of its business in FY 2026, I don't expect this to be for long. Macquarie has a long history of adapting to changing conditions. Its asset management division continues to grow funds under management, while its infrastructure expertise positions it well for long-term global investment trends.

For investors looking for an ASX 200 share with exposure well beyond the domestic economy, Macquarie remains a high-quality option to consider early in the year.

Woolworths Group Ltd (ASX: WOW)

Woolworths may not be the most exciting stock on the market, but its reliability is exactly what makes it appealing. As one of Australia's dominant supermarket operators, it generates steady cash flow regardless of economic conditions.

Margin pressure and increased competition have been weighing on its performance over the past 12 months, but there are signs that the worst is now behind it. In addition, during this time Woolworths has continued to invest heavily in automation, supply chain efficiency, and digital capability. Over time, I believe these investments will bear fruit and position it for the future.

For investors building a balanced ASX 200 portfolio, Woolworths offers defensive characteristics that can complement higher-growth holdings. And with its shares down meaningfully from their highs, now could be an opportune time to load up on them.

Motley Fool contributor James Mickleboro has positions in CSL and Woolworths Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and Woolworths Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Woman with her kitten on a laptop in her home office.
Blue Chip Shares

Buy, hold, sell: Coles, Woodside & Telstra shares

Find out what the experts tip for these three well-known ASX shares.

Read more »

Person holding a blue chip.
Blue Chip Shares

2 ASX blue-chip shares experts rate as compelling

These businesses have a compelling outlook according to fund managers…

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses can deliver investors pleasing passive income.

Read more »

Stressed shopper holding shopping bags.
Retail Shares

Should I invest $6,000 in Wesfarmers shares in August?

Here's what brokers tip for the retail conglomerate’s shares now.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

Down 31%: Is it time to buy this popular ASX 200 blue chip?

Is it time to be bullish or bearish on this fallen giant? Here's what analysts are saying.

Read more »

A man surrounded by huge piles of paper looks through a magnifying glass at his computer screen.
Blue Chip Shares

Buy, hold, sell: Telstra, BHP, CSL shares

At the time of writing, brokers tip some element of upside from each of these ASX shares. Find out more…

Read more »

A man wearing a colourful shirt holds an old fashioned phone to his ear with a look of curiosity on his face as though he is pondering the answer to a question.
Dividend Investing

If you invested $10,000 in Telstra shares 10 years ago, here's what you'd have today

The capital went backwards. The income did the work.

Read more »

A casually dressed woman at home on her couch looks at index fund charts on her laptop.
Blue Chip Shares

My highest-conviction ASX share for August

The business is already a global leader, yet its market may still be in the early stages.

Read more »